FR2244481A1 - Oral treatment of diabetes - with a complex of glibenclamide and phenformin - Google Patents

Oral treatment of diabetes - with a complex of glibenclamide and phenformin

Info

Publication number
FR2244481A1
FR2244481A1 FR7432021A FR7432021A FR2244481A1 FR 2244481 A1 FR2244481 A1 FR 2244481A1 FR 7432021 A FR7432021 A FR 7432021A FR 7432021 A FR7432021 A FR 7432021A FR 2244481 A1 FR2244481 A1 FR 2244481A1
Authority
FR
France
Prior art keywords
complex
diabetes
oral treatment
phenformin
glibenclamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7432021A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2244481A1 publication Critical patent/FR2244481A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7432021A 1973-09-21 1974-09-23 Oral treatment of diabetes - with a complex of glibenclamide and phenformin Withdrawn FR2244481A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732347531 DE2347531A1 (de) 1973-09-21 1973-09-21 Arzneizubereitungen zur oralen diabetes-behandlung

Publications (1)

Publication Number Publication Date
FR2244481A1 true FR2244481A1 (en) 1975-04-18

Family

ID=5893251

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7432021A Withdrawn FR2244481A1 (en) 1973-09-21 1974-09-23 Oral treatment of diabetes - with a complex of glibenclamide and phenformin

Country Status (12)

Country Link
JP (1) JPS5053521A ( )
AU (1) AU7349374A ( )
BE (1) BE820222A ( )
DE (1) DE2347531A1 ( )
DK (1) DK496774A ( )
FI (1) FI274174A ( )
FR (1) FR2244481A1 ( )
IL (1) IL45690A0 ( )
NL (1) NL7412254A ( )
NO (1) NO743394L ( )
SE (1) SE7411852L ( )
ZA (1) ZA745981B ( )

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816841A1 (fr) * 2000-11-22 2002-05-24 Lipha Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
WO2003045355A1 (en) * 2001-11-29 2003-06-05 Menarini International Operations Luxembourg S.A. Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61260013A (ja) * 1985-05-14 1986-11-18 Katsumi Takada 三部分からなる多層錠
TR199701092T1 (xx) * 1995-04-03 1998-01-21 Chugai Seiyaku Kabushiki Kaisha Et Al Sukralfat içeren farmakotik kompozisyonlar.
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
CA2725833A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816841A1 (fr) * 2000-11-22 2002-05-24 Lipha Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
WO2002041897A2 (fr) * 2000-11-22 2002-05-30 Lipha S.A. Compositions pharmaceutiques a action antidiabetique constitues de l'association d'un biguanide et d'un sulfonamide
WO2002041879A2 (en) * 2000-11-22 2002-05-30 Merck Patent Gmbh Antidiabetic compositions containing a biguanide and a sulfonamide
WO2002041879A3 (en) * 2000-11-22 2003-05-22 Merck Patent Gmbh Antidiabetic compositions containing a biguanide and a sulfonamide
WO2002041897A3 (fr) * 2000-11-22 2003-05-30 Lipha Compositions pharmaceutiques a action antidiabetique constitues de l'association d'un biguanide et d'un sulfonamide
WO2003045355A1 (en) * 2001-11-29 2003-06-05 Menarini International Operations Luxembourg S.A. Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
AU2002358061B2 (en) * 2001-11-29 2007-01-11 Menarini International Operations Luxembourg S.A. Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-II diabetes mellitus

Also Published As

Publication number Publication date
DE2347531A1 (de) 1975-04-30
NL7412254A (nl) 1975-03-25
AU7349374A (en) 1976-03-25
FI274174A ( ) 1975-03-22
NO743394L ( ) 1975-04-14
IL45690A0 (en) 1974-11-29
BE820222A (fr) 1975-03-24
DK496774A ( ) 1975-05-26
JPS5053521A ( ) 1975-05-12
SE7411852L ( ) 1975-03-24
ZA745981B (en) 1975-10-29

Similar Documents

Publication Publication Date Title
NO165540C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n,n-dimetyl-1-(1-(4-klorfenyl)cyklobutyl)-3-metylbutylamin-hydroklorid-monohydrat.
HK1000913A1 (en) Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease
KR900701261A (ko) 비만증 치료방법
HK129393A (en) Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of complications of diabetes mellitus
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
IL72469A0 (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
GB8908085D0 (en) New therapeutic use
NO163569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-thioxanthinderivater.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
FR2244481A1 (en) Oral treatment of diabetes - with a complex of glibenclamide and phenformin
GB1381184A (en) Sulphamides
IE38655B1 (en) Pharmaceutical compositions for treating spasticity
FR2320735A1 (fr) Composition anti-cellulite
MY102991A (en) Medicaments for treating hypertension.
Shanks et al. Stimulation of adrenergic beta-receptors by orciprenaline.
IL52547A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide its optical isomers its n-oxide and pharmaceutically acceptable salts thereof their preparation and pharmaceutical compoistions containing them
CA1029305A (en) Infusion solution for the treatment of tachycardiac disturbances of heart rhythm and use thereof
ES8203086A1 (es) Un procedimiento para la produccion de n,n'-bis-(3-picolil) -4-metoxi-isoftalamida monohidratada
FR2447368A1 (fr) Derives de la phenylethylamine, leur preparation et medicament contenant ces substances
NO152253C (no) Analogifremgangsmaate for fremstlling av 4-(n-(3`,4`-dihydroksybenzyliden)aminometyl)-cykloheksan-1-karboksylsyre med terapeutisk aktivitet
AU555496B2 (en) Phenoxypyridine ffor normalizing hippocampal function
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
FR2137186A1 (en) Folic acid salts - used as neuro-stimulants and for dynamising muscular function
ES450206A1 (es) Un procedimiento para la preparacion de 1, 2, 3, 4-tetrahi- droisoquinoleinas.
GR3019176T3 (en) Medicament containing a combination of AZT and amantadin for the treatment of AIDS.

Legal Events

Date Code Title Description
ST Notification of lapse